Interestingly, consistent with the objective response of the right lower lobe lung mass and mediastinal/right hilar lymph nodes by imaging assessment, SLC8A1-ALK intergenic fusion could not be detected in peripheral blood (Fig. 3H), accurately reflecting the real-time tumor response to ceritinib therapy. The gene discussed is ALK; the disease is neoplasm.